<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Aripiprazole metabolic pathway" Author="Egon Willighagen" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The CYP P450 metabolism of aripiprazole has been studied and described in several papers (like the one in the bibliography), except for the original primary literature describing the experiments and the exact metabolite structures. The two CYPs are said to be involved in N-dealkylation and dehydrogenation. </Comment>
  <BiopaxRef>bcf</BiopaxRef>
  <BiopaxRef>f29</BiopaxRef>
  <BiopaxRef>e76</BiopaxRef>
  <BiopaxRef>ba3</BiopaxRef>
  <BiopaxRef>f97</BiopaxRef>
  <Graphics BoardWidth="512.0" BoardHeight="233.0"/>
  <DataNode TextLabel="CYP2D6" GraphId="c1ed5" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="aripiprazole" GraphId="cf694" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="dehydroaripiprazole" GraphId="d02eb" Type="Metabolite">
    <Comment>Also known as OPC14857.</Comment>
    <BiopaxRef>e76</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Product" GraphId="dd805" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP3A43" GraphId="ef6ee" Type="GeneProduct">
        </DataNode>
  <Interaction GraphId="id403afc34">
    <Graphics>
      <Point GraphRef="c1ed5"/>
      <Point GraphRef="e20cc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6b0af018">
    <Graphics>
      <Point GraphRef="ef6ee"/>
      <Point GraphRef="baa08" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7653b8d8">
    <Graphics>
      <Point GraphRef="cf694"/>
      <Point GraphRef="dd805" ArrowHead="Arrow"/>
      <Anchor Position="0.5" Shape="None" GraphId="baa08"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf965780e">
    <Graphics>
      <Point GraphRef="cf694"/>
      <Point GraphRef="d02eb" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5" Shape="None" GraphId="e20cc"/>
    </Graphics>
    </Interaction>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e76">
      <bp:ID >15770075</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.</bp:TITLE>
      <bp:SOURCE >Drug Metab Pharmacokinet</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Kubo M</bp:AUTHORS>
      <bp:AUTHORS >Koue T</bp:AUTHORS>
      <bp:AUTHORS >Inaba A</bp:AUTHORS>
      <bp:AUTHORS >Takeda H</bp:AUTHORS>
      <bp:AUTHORS >Maune H</bp:AUTHORS>
      <bp:AUTHORS >Fukuda T</bp:AUTHORS>
      <bp:AUTHORS >Azuma J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f97">
      <bp:ID >17214606</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolic drug interactions with newer antipsychotics: a comparative review.</bp:TITLE>
      <bp:SOURCE >Basic Clin Pharmacol Toxicol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Spina E</bp:AUTHORS>
      <bp:AUTHORS >de Leon J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba3">
      <bp:ID >17164689</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.</bp:TITLE>
      <bp:SOURCE >Ther Drug Monit</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Molden E</bp:AUTHORS>
      <bp:AUTHORS >Lunde H</bp:AUTHORS>
      <bp:AUTHORS >Lunder N</bp:AUTHORS>
      <bp:AUTHORS >Refsum H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f29">
      <bp:ID >15257633</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.</bp:TITLE>
      <bp:SOURCE >Drugs</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Swainston Harrison T</bp:AUTHORS>
      <bp:AUTHORS >Perry CM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >xenobiotic metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001229</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bcf">
      <bp:ID >14998222</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Aripiprazole, a novel atypical antipsychotic drug.</bp:TITLE>
      <bp:SOURCE >Pharmacotherapy</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Argo TR</bp:AUTHORS>
      <bp:AUTHORS >Carnahan RM</bp:AUTHORS>
      <bp:AUTHORS >Perry PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >phase I biotransformation pathway via cytochrome P450</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000375</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>